1,057
Views
71
CrossRef citations to date
0
Altmetric
Research Article

Senataxin mutations and amyotrophic lateral sclerosis

, , , , , & show all
Pages 223-227 | Received 09 Aug 2010, Accepted 04 Dec 2010, Published online: 29 Dec 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

I. Andreini, F. Moro, L.M. Africa, A. Rubegni, F.M. Santorelli, C. Scarpini, F. Sicurelli & C. Battisti. (2020) Rare phenotype of ALS4 associated with heterozygous missense mutation c.5842A > G/p.M1948V in helicase domain of SETX gene. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:3-4, pages 312-313.
Read now
Afnan A Alsultan, Rachel Waller, Paul R Heath & Janine Kirby. (2016) The genetics of amyotrophic lateral sclerosis: current insights. Degenerative Neurological and Neuromuscular Disease 6, pages 49-64.
Read now
Zhang-Yu Zou, Ming-Sheng Liu, Xiao-Guang Li & Li-Ying Cui. (2016) Mutations in FUS are the most frequent genetic cause in juvenile sporadic ALS patients of Chinese origin. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:3-4, pages 249-252.
Read now
Hikaru Sakamoto, Maiko Akamatsu, Makito Hirano, Kazumasa Saigoh, Shuichi Ueno, Chiharu Isono, Susumu Kusunoki & Yusaku Nakamura. (2014) Multiple system involvement in a Japanese patient with a V31A mutation in the SOD1 gene. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:3-4, pages 312-314.
Read now
Enrico Saracchi, Marianna Castelli, Maria T. Bassi, Erika Brighina, Diletta Cereda, Laura Marzorati, Mirko Patassini, Ildebrando Appollonio, Carlo Ferrarese & Laura Brighina. (2014) A novel heterozygous SETX mutation in a patient presenting with chorea and motor neuron disease. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:1-2, pages 138-140.
Read now
Patricia Richard & James L Manley. (2014) SETX sumoylation. Rare Diseases 2:1.
Read now
. (2013) THEME 6 EPIDEMIOLOGY. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 14:sup2, pages 137-147.
Read now
Francesca Avemaria, Christian Lunetta, Claudia Tarlarini, Lorena Mosca, Eleonora Maestri, Alessandro Marocchi, Mario Melazzini, Silvana Penco & Massimo Corbo. (2011) Mutation in the senataxin gene found in a patient affected by familial ALS with juvenile onset and slow progression. Amyotrophic Lateral Sclerosis 12:3, pages 228-230.
Read now

Articles from other publishers (63)

Michele Salemi, Giuseppe Lanza, Maria Grazia Salluzzo, Francesca A. Schillaci, Francesco Domenico Di Blasi, Angela Cordella, Salvatore Caniglia, Bartolo Lanuzza, Manuela Morreale, Pietro Marano, Mariangela Tripodi & Raffaele Ferri. (2023) A Next-Generation Sequencing Study in a Cohort of Sicilian Patients with Parkinson’s Disease. Biomedicines 11:12, pages 3118.
Crossref
Marta Giannini & Odil Porrua. (2023) Senataxin: A key actor in RNA metabolism, genome integrity and neurodegeneration. Biochimie.
Crossref
Katherine E. Bohnsack, Soon Yi, Sarah Venus, Eckhard Jankowsky & Markus T. Bohnsack. (2023) Cellular functions of eukaryotic RNA helicases and their links to human diseases. Nature Reviews Molecular Cell Biology.
Crossref
Sina Shadfar, Sonam Parakh, Md Shafi Jamali & Julie D. Atkin. (2023) Redox dysregulation as a driver for DNA damage and its relationship to neurodegenerative diseases. Translational Neurodegeneration 12:1.
Crossref
Zdenka Hasanova, Veronika Klapstova, Odil Porrua, Richard Stefl & Marek Sebesta. (2023) Human senataxin is a bona fide R-loop resolving enzyme and transcription termination factor. Nucleic Acids Research 51:6, pages 2818-2837.
Crossref
Rupesh Kumar, Zubbair Malik, Manisha Singh, R. Rachana, Shalini Mani, Kalaiarasan Ponnusamy & Shazia Haider. (2023) Amyotrophic Lateral Sclerosis Risk Genes and Suppressor. Current Gene Therapy 23:2, pages 148-162.
Crossref
Maia Farrugia Wismayer, Andrew Farrugia Wismayer, Rebecca Borg, Karl Bonavia, André Abela, Charmaine Chircop, Josanne Aquilina, Doriette Soler, Adrian Pace, Malcolm Vella, Neville Vassallo & Ruben J. Cauchi. (2023) Genetic landscape of ALS in Malta based on a quinquennial analysis. Neurobiology of Aging 123, pages 200-207.
Crossref
Anni Zhang, Hongbei Xu, Jing Huang, Huilan Gong, Shipeng Guo, Xiaoyang Lei & Dian He. (2022) Coexisting amyotrophic lateral sclerosis and chorea: A case report and literature review. Medicine 101:52, pages e32452.
Crossref
G. E. Rudenskaya, S. S. Nikitin, O. L. Shatokhina & O. A. Shchagina. (2022) Juvenile amyotrophic lateral sclerosis type 4: case report and review. Neuromuscular Diseases 12:3, pages 52-58.
Crossref
Amandeep Girdhar & Lin Guo. (2022) Regulating Phase Transition in Neurodegenerative Diseases by Nuclear Import Receptors. Biology 11:7, pages 1009.
Crossref
Rupesh Kumar & Shazia Haider. (2022) Protein network analysis to prioritize key genes in amyotrophic lateral sclerosis. IBRO Neuroscience Reports 12, pages 25-44.
Crossref
Vincent E. Provasek, Joy Mitra, Vikas H. Malojirao & Muralidhar L. Hegde. (2022) DNA Double-Strand Breaks as Pathogenic Lesions in Neurological Disorders. International Journal of Molecular Sciences 23:9, pages 4653.
Crossref
Jinwoo Lee, Subin An, Sang-Jin Lee & Jong-Sun Kang. (2022) Protein Arginine Methyltransferases in Neuromuscular Function and Diseases. Cells 11:3, pages 364.
Crossref
Kathryn Volkening, Sali M. K. Farhan, Jessica Kao, Cheryl Leystra-Lantz, Lee Cyn Ang, Adam McIntyre, Jian Wang, Robert A. Hegele & Michael J. Strong. (2021) Evidence of synergism among three genetic variants in a patient with LMNA-related lipodystrophy and amyotrophic lateral sclerosis leading to a remarkable nuclear phenotype. Molecular and Cellular Biochemistry 476:7, pages 2633-2650.
Crossref
Nader Akbari Dilmaghani, Bashdar Mahmud Hussen, Saeedeh Nateghinia, Mohammad Taheri & Soudeh Ghafouri-Fard. (2021) Emerging role of microRNAs in the pathogenesis of amyotrophic lateral sclerosis. Metabolic Brain Disease 36:5, pages 737-749.
Crossref
L. Chen. (2021) FUS mutation is probably the most common pathogenic gene for JALS, especially sporadic JALS. Revue Neurologique 177:4, pages 333-340.
Crossref
Nachiyappan Venkatachalam, Shamchal Bakavayev, Daniel Engel, Zeev Barak & Stanislav Engel. (2020) Primate differential redoxome (PDR) – A paradigm for understanding neurodegenerative diseases. Redox Biology 36, pages 101683.
Crossref
Arijit Dutta, Robert Hromas & Patrick Sung. 2020. Amyotrophic Lateral Sclerosis - Recent Advances and Therapeutic Challenges. Amyotrophic Lateral Sclerosis - Recent Advances and Therapeutic Challenges.
Vincent Picher-Martel, Francis BrunetNicolas Dupré & Nicolas Chrestian. (2020) The Occurrence of FUS Mutations in Pediatric Amyotrophic Lateral Sclerosis: A Case Report and Review of the Literature. Journal of Child Neurology 35:8, pages 556-562.
Crossref
André Brannvoll, Xiaoyu Xue, Youngho Kwon, Smaragdi Kompocholi, Anne Katrine W. Simonsen, Keerthana S. Viswalingam, Leticia Gonzalez, Ian D. Hickson, Vibe H. Oestergaard, Hocine W. Mankouri, Patrick Sung & Michael Lisby. (2020) The ZGRF1 Helicase Promotes Recombinational Repair of Replication-Blocking DNA Damage in Human Cells. Cell Reports 32:1, pages 107849.
Crossref
Christopher Grunseich, Aneesh Patankar, Joshua Amaya, Jason A. Watts, Dongjun Li, Prisila Ramirez, Alice B. Schindler, Kenneth H. Fischbeck & Vivian G. Cheung. (2020) Clinical and Molecular Aspects of Senataxin Mutations in Amyotrophic Lateral Sclerosis 4. Annals of Neurology 87:4, pages 547-555.
Crossref
Viviana Pensato, Stefania Magri, Eleonora Dalla Bella, Pierpaola Tannorella, Enrica Bersano, Gianni Sorarù, Marta Gatti, Nicola Ticozzi, Franco Taroni, Giuseppe Lauria, Caterina Mariotti & Cinzia Gellera. (2020) Sorting Rare ALS Genetic Variants by Targeted Re-Sequencing Panel in Italian Patients: OPTN, VCP, and SQSTM1 Variants Account for 3% of Rare Genetic Forms. Journal of Clinical Medicine 9:2, pages 412.
Crossref
Ruriko Kitao, Yutaka HonmaAkihiro Hashiguchi, Kouichi MizoguchiHiroshi Takashima & Tetsuo Komori. (2020) A case of motor and sensory polyneuropathy and respiratory failure with novel heterozygous mutation of the senataxin gene運動感覚性末梢神経障害と呼吸不全を呈しセナタキシン遺伝子にヘテロ接合性の新規変異を認めた1例. Rinsho Shinkeigaku 60:7, pages 466-472.
Crossref
Rita Mejzini, Loren L. Flynn, Ianthe L. Pitout, Sue Fletcher, Steve D. Wilton & P. Anthony Akkari. (2019) ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?. Frontiers in Neuroscience 13.
Crossref
Priyam Narain, Aditya K. Padhi, Upma Dave, Dibyakanti Mishra, Rohit Bhatia, Perumal Vivekanandan & James Gomes. (2019) Identification and characterization of novel and rare susceptible variants in Indian amyotrophic lateral sclerosis patients. neurogenetics 20:4, pages 197-208.
Crossref
Udaya Geetha Vijayakumar, Vanessa Milla, Mei Yu Cynthia Stafford, Anthony J. Bjourson, William Duddy & Stephanie Marie-Rose Duguez. (2019) A Systematic Review of Suggested Molecular Strata, Biomarkers and Their Tissue Sources in ALS. Frontiers in Neurology 10.
Crossref
Archana Prasad, Vidhya Bharathi, Vishwanath Sivalingam, Amandeep Girdhar & Basant K. Patel. (2019) Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis. Frontiers in Molecular Neuroscience 12.
Crossref
Seth A. Bennett, Royena Tanaz, Samantha N. Cobos & Mariana P. Torrente. (2019) Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease. Translational Research 204, pages 19-30.
Crossref
Zhi-Jun Liu, Hui-Xia Lin, Qiao Wei, Qi-Jie Zhang, Cong-Xin Chen, Qing-Qing Tao, Gong-Lu Liu, Wang Ni, Aaron D Gitler, Hong-Fu Li & Zhi-Ying Wu. (2019) Genetic Spectrum and Variability in Chinese Patients with Amyotrophic Lateral Sclerosis. Aging and disease 10:6, pages 1199.
Crossref
Merit Lamp, Paola Origone, Alessandro Geroldi, Simonetta Verdiani, Fabio Gotta, Claudia Caponnetto, Grazia Devigili, Lorenzo Verriello, Carlo Scialò, Corrado Cabona, Antonio Canosa, Irene Vanni, Emilia Bellone, Roberto Eleopra & Paola Mandich. (2018) Twenty years of molecular analyses in amyotrophic lateral sclerosis: genetic landscape of Italian patients. Neurobiology of Aging 66, pages 179.e5-179.e16.
Crossref
Y.-H. Taguchi & Hsiuying Wang. (2018) Exploring microRNA Biomarker for Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences 19:5, pages 1318.
Crossref
Joy Goffena, Frances Lefcort, Yongqing Zhang, Elin Lehrmann, Marta Chaverra, Jehremy Felig, Joseph Walters, Richard Buksch, Kevin G. Becker & Lynn George. (2018) Elongator and codon bias regulate protein levels in mammalian peripheral neurons. Nature Communications 9:1.
Crossref
Paola Rinchetti, Mafalda Rizzuti, Irene Faravelli & Stefania Corti. (2017) MicroRNA Metabolism and Dysregulation in Amyotrophic Lateral Sclerosis. Molecular Neurobiology 55:3, pages 2617-2630.
Crossref
Stephen A. Goutman, Kevin S. Chen, Ximena Paez-Colasante & Eva L. Feldman. 2018. Neurogenetics, Part II. Neurogenetics, Part II 603 623 .
Johnathan Cooper-Knock, Henry Robins, Isabell Niedermoser, Matthew Wyles, Paul R. Heath, Adrian Higginbottom, Theresa Walsh, Mbombe Kazoka, Paul G. Ince, Guillaume M. Hautbergue, Christopher J. McDermott, Janine Kirby & Pamela J. Shaw. (2017) Targeted Genetic Screen in Amyotrophic Lateral Sclerosis Reveals Novel Genetic Variants with Synergistic Effect on Clinical Phenotype. Frontiers in Molecular Neuroscience 10.
Crossref
Patricia Richard & James L. Manley. (2017) R Loops and Links to Human Disease. Journal of Molecular Biology 429:21, pages 3168-3180.
Crossref
Tanea T. Reed & D. Allan Butterfield. 2017. Protein Carbonylation. Protein Carbonylation 167 205 .
C. Tard, L. Defebvre, C. Moreau, D. Devos & V. Danel-Brunaud. (2017) Clinical features of amyotrophic lateral sclerosis and their prognostic value. Revue Neurologique 173:5, pages 263-272.
Crossref
Ayumi Nishiyama, Tetsuya Niihori, Hitoshi Warita, Rumiko Izumi, Tetsuya Akiyama, Masaaki Kato, Naoki Suzuki, Yoko Aoki & Masashi Aoki. (2017) Comprehensive targeted next-generation sequencing in Japanese familial amyotrophic lateral sclerosis. Neurobiology of Aging 53, pages 194.e1-194.e8.
Crossref
Kornélia Tripolszki, Dóra Török, David Goudenège, Katalin Farkas, Adrienn Sulák, Nóra Török, József I. Engelhardt, Péter Klivényi, Vincent Procaccio, Nikoletta Nagy & Márta Széll. (2017) High-throughput sequencing revealed a novel SETX mutation in a Hungarian patient with amyotrophic lateral sclerosis. Brain and Behavior 7:4, pages e00669.
Crossref
Lavinia C. Dumitrache & Peter J. McKinnon. (2017) Polynucleotide kinase-phosphatase (PNKP) mutations and neurologic disease. Mechanisms of Ageing and Development 161, pages 121-129.
Crossref
Hong-Fu Li & Zhi-Ying Wu. (2016) Genotype-phenotype correlations of amyotrophic lateral sclerosis. Translational Neurodegeneration 5:1.
Crossref
Steven G. Friedenberg, Kathryn M. Meurs & Trudy F. C. Mackay. (2016) Evaluation of artificial selection in Standard Poodles using whole-genome sequencing. Mammalian Genome 27:11-12, pages 599-609.
Crossref
Elisa Gregianin, Giorgia Pallafacchina, Sofia Zanin, Valeria Crippa, Paola Rusmini, Angelo Poletti, Mingyan Fang, Zhouxuan Li, Laura Diano, Antonio Petrucci, Ludovico Lispi, Tiziana Cavallaro, Gian M. Fabrizi, Maria Muglia, Francesca Boaretto, Andrea Vettori, Rosario Rizzuto, Maria L. Mostacciuolo & Giovanni Vazza. (2016) Loss-of-function mutations in the SIGMAR1 gene cause distal hereditary motor neuropathy by impairing ER-mitochondria tethering and Ca 2+ signalling . Human Molecular Genetics 25:17, pages 3741-3753.
Crossref
Fang HeJulie M. JonesClaudia Figueroa-RomeroDapeng ZhangEva L. FeldmanStephen A. GoutmanMiriam H. MeislerBrian C. CallaghanPeter K. Todd. (2016) Screening for novel hexanucleotide repeat expansions at ALS- and FTD-associated loci. Neurology Genetics 2:3.
Crossref
Diane Moujalled & Anthony R. White. (2016) Advances in the Development of Disease-Modifying Treatments for Amyotrophic Lateral Sclerosis. CNS Drugs 30:3, pages 227-243.
Crossref
Elena Ratti & James D. Berry. 2016. Genomics, Circuits, and Pathways in Clinical Neuropsychiatry. Genomics, Circuits, and Pathways in Clinical Neuropsychiatry 685 712 .
Abrey J Yeo, Olivier J Becherel, John E Luff, Mark E Graham, Derek Richard & Martin F Lavin. (2015) Senataxin controls meiotic silencing through ATR activation and chromatin remodeling. Cell Discovery 1:1.
Crossref
Ximena Paez-Colasante, Claudia Figueroa-Romero, Stacey A. Sakowski, Stephen A. Goutman & Eva L. Feldman. (2015) Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era. Nature Reviews Neurology 11:5, pages 266-279.
Crossref
Tanea Reed, Zachariah Sellers & D Butterfield. 2015. Lipid Oxidation in Health and Disease. Lipid Oxidation in Health and Disease 329 362 .
Alexander P. Drew, Danqing Zhu, Aditi Kidambi, Carolyn Ly, Shelisa Tey, Megan H. Brewer, Azlina Ahmad‐Annuar, Garth A. Nicholson & Marina L. Kennerson. (2015) Improved inherited peripheral neuropathy genetic diagnosis by whole‐exome sequencing. Molecular Genetics & Genomic Medicine 3:2, pages 143-154.
Crossref
Chiara Vantaggiato, Orazio Cantoni, Andrea Guidarelli, Romina Romaniello, Andrea Citterio, Filippo Arrigoni, Chiara Doneda, Marianna Castelli, Giovanni Airoldi, Nereo Bresolin, Renato Borgatti & Maria Teresa Bassi. (2014) Novel SETX variants in a patient with ataxia, neuropathy, and oculomotor apraxia are associated with normal sensitivity to oxidative DNA damaging agents. Brain and Development 36:8, pages 682-689.
Crossref
Xiaowei W. Su, James R. Broach, James R. Connor, Glenn S. Gerhard & Zachary Simmons. (2014) Genetic heterogeneity of amyotrophic lateral sclerosis: Implications for clinical practice and research. Muscle & Nerve 49:6, pages 786-803.
Crossref
Matthew B. Harms & Robert H. Baloh. (2013) Clinical Neurogenetics. Neurologic Clinics 31:4, pages 929-950.
Crossref
Frank Krieger, Nicole Elflein, Rocio Ruiz, Joana Guerra, Antonio L. Serrano, Esther Asan, Lucia Tabares & Sibylle Jablonka. (2013) Fast motor axon loss in SMARD1 does not correspond to morphological and functional alterations of the NMJ. Neurobiology of Disease 54, pages 169-182.
Crossref
Kevin P. Kenna, Russell L. McLaughlin, Orla Hardiman & Daniel G. Bradley. (2013) Using Reference Databases of Genetic Variation to Evaluate the Potential Pathogenicity of Candidate Disease Variants. Human Mutation 34:6, pages 836-841.
Crossref
Matthew Thomas, Javier Alegre-Abarrategui & Richard Wade-Martins. (2013) RNA dysfunction and aggrephagy at the centre of an amyotrophic lateral sclerosis/frontotemporal dementia disease continuum. Brain 136:5, pages 1345-1360.
Crossref
Larissa Arning, Jörg T. Epplen, Elisa Rahikkala, Corinna Hendrich, Albert C. Ludolph & Anne-Dorte Sperfeld. (2012) The SETX missense variation spectrum as evaluated in patients with ALS4-like motor neuron diseases. neurogenetics 14:1, pages 53-61.
Crossref
D. Allan ButterfieldMarzia PerluigiTanea ReedTasneem MuharibChristopher P. HughesRenã A.S. RobinsonRukhsana Sultana. (2012) Redox Proteomics in Selected Neurodegenerative Disorders: From Its Infancy to Future Applications. Antioxidants & Redox Signaling 17:11, pages 1610-1655.
Crossref
Sabine Rudnik-Schöneborn, Larissa Arning, Jörg T. Epplen & Klaus Zerres. (2012) SETX gene mutation in a family diagnosed autosomal dominant proximal spinal muscular atrophy. Neuromuscular Disorders 22:3, pages 258-262.
Crossref
Fadia IbrahimTadashi NakayaZissimos Mourelatos. (2012) RNA Dysregulation in Diseases of Motor Neurons. Annual Review of Pathology: Mechanisms of Disease 7:1, pages 323-352.
Crossref
Peter M. Andersen & Ammar Al-Chalabi. (2011) Clinical genetics of amyotrophic lateral sclerosis: what do we really know?. Nature Reviews Neurology 7:11, pages 603-615.
Crossref
Tanea T. Reed. (2011) Lipid peroxidation and neurodegenerative disease. Free Radical Biology and Medicine 51:7, pages 1302-1319.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.